Person attributes
Tom Lavin is a co-founder and Partner of New Science Ventures. He serves on the Board of Directors for Achronix Semiconductor Corporation, Light Sciences Oncology and Perceptimed and is an observer on the boards of Juventas Therapeutics and Vorago. He formerly served on the Board of Celleration (acquired by Aliqua). Prior to NSV, he was a senior professional in finance and investment banking for over 30 years. Tom has extensive experience in private and public equity and debt transactions, mergers and acquisitions and financial restructurings in the U.S. and abroad. He was head of real estate investment banking at First Boston and Smith Barney and head of commercial mortgage lending at MetLife. Tom holds an A.B. degree in Government from Wesleyan University and an M.B.A. from Harvard Business School.
